Bradley J Kerr Selected Research

Phenelzine (Nardil)

1/2018	Antinociceptive Effects of the Antidepressant Phenelzine are Mediated by Context-Dependent Inhibition of Neuronal Responses in the Dorsal Horn.
9/2013	The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
11/2011	The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bradley J Kerr Research Topics

Disease

10	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 08/2011
8	Pain (Aches) 01/2022 - 01/2016
6	Inflammation (Inflammations) 01/2022 - 09/2001
6	Neuralgia (Stump Neuralgia) 01/2022 - 01/2009
6	Multiple Sclerosis 01/2021 - 08/2011
5	Hyperalgesia 01/2022 - 09/2001
4	Spinal Cord Injuries (Spinal Cord Injury) 12/2011 - 07/2005
3	Hypersensitivity (Allergy) 01/2022 - 03/2013
3	Chronic Pain 01/2021 - 02/2014
2	Demyelinating Diseases (Demyelinating Disease) 03/2019 - 12/2011
1	Autoimmune Diseases of the Nervous System 03/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2018
1	Polyneuropathies (Polyneuropathy) 01/2018
1	Huntington Disease (Huntington's Disease) 11/2017
1	Rheumatoid Arthritis 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Peripheral Nerve Injuries 08/2011
1	Disease Progression 11/2010
1	Hemorrhagic Stroke 11/2008
1	Hemorrhage 11/2008
1	Wounds and Injuries (Trauma) 11/2008
1	Contusions 08/2007
1	Mental Disorders (Mental Disorder) 03/2007

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2021 - 07/2005
3	Myelin-Oligodendrocyte GlycoproteinIBA 03/2019 - 01/2009
3	Phenelzine (Nardil)FDA Link 01/2018 - 11/2011
3	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 04/2016 - 11/2011
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2021
2	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021 - 08/2011
2	AntigensIBA 01/2017 - 11/2010
2	Analgesics (Analgesic Drugs)IBA 01/2017 - 02/2014
2	gamma-Aminobutyric Acid (GABA)IBA 04/2016 - 09/2013
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 09/2013
2	protein kinase C gamma (PRKCG)IBA 03/2013 - 08/2007
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Potassium Channels (Potassium Channel)IBA 01/2020
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2020
1	CalciumIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 11/2019
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Messenger RNA (mRNA)IBA 03/2019
1	Myelin ProteinsIBA 03/2019
1	SteroidsIBA 10/2018
1	N-Methylaspartate (NMDA)IBA 10/2018
1	GABA-A Receptors (GABA(A) Receptor)IBA 10/2018
1	NeurosteroidsIBA 10/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	G(M1) GangliosideIBA 11/2017
1	GTP Phosphohydrolases (GTPases)IBA 01/2017
1	AutoantibodiesIBA 01/2017
1	GuanosineIBA 01/2017
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 04/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Biological ProductsIBA 02/2014
1	Monoamine Oxidase (MAO)IBA 09/2013
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 03/2013
1	Nonesterified Fatty Acids (NEFA)IBA 12/2011
1	LysophospholipidsIBA 12/2011
1	Phospholipases A2 (Phospholipase A2)IBA 12/2011
1	Arachidonic Acid (Vitamin F)IBA 12/2011
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 12/2011
1	EicosanoidsIBA 12/2011
1	Interleukin-1 (Interleukin 1)IBA 08/2011
1	Biogenic Amines (Biogenic Amine)IBA 08/2011
1	Amino Acids FDA Link 08/2011
1	NeuropeptidesIBA 01/2009
1	IronIBA 11/2008
1	Chelating AgentsIBA 11/2008
1	NF-kappa B (NF-kB)IBA 03/2008
1	Prostaglandin D2IBA 03/2008
1	15-deoxyprostaglandin J2IBA 03/2008
1	15-deoxy-delta(12,14)-prostaglandin J2IBA 03/2008
1	Phosphotransferases (Kinase)IBA 03/2008
1	A-factor (Streptomyces)IBA 03/2007
1	Leukemia Inhibitory FactorIBA 07/2005
1	GalaninIBA 09/2001
1	CarrageenanIBA 09/2001

Therapy/Procedure

4	Therapeutics 01/2021 - 11/2008
1	Analgesia 01/2022
1	Denervation 01/2018